Tandem Diabetes Care (TNDM) Operating Leases (2019 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Operating Leases came in at $133.0 million in Q1 2026, up 8.06% YoY from $123.0 million in Q1 2025, and up 15.66% on a QoQ basis from $115.0 million in Q4 2025.
Tandem Diabetes Care (TNDM) Operating Leases (2019 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 8 years of Operating Leases data on file, last reported at $133.0 million in Q1 2026.
- Quarterly Operating Leases rose 8.06% year-over-year to $133.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $133.0 million (up 8.06% YoY) and the FY2025 annual result came in at $115.0 million, up 8.03% from the prior year.
- Operating Leases climbed to $133.0 million in Q1 2026, from $115.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $139.9 million in Q2 2025 to a low of $3.0 million in Q2 2022.
- A 5-year average of $113.7 million and a median of $116.0 million in 2023 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases plunged 89.04% — and 2023, when it soared 3846.67%.
- Tracing TNDM's Operating Leases over 5 years: stood at $123.5 million in 2022, then slipped by 8.06% to $113.6 million in 2023, then decreased by 6.3% to $106.4 million in 2024, then grew by 8.03% to $115.0 million in 2025, then climbed by 15.66% to $133.0 million in 2026.
- The last three Operating Leases figures came in at $133.0 million (Q1 2026), $115.0 million (Q4 2025), and $139.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136.68 Mn |
| Mar 31, 2026 | 132.97 Mn |
| Dec 31, 2025 | 114.97 Mn |
| Sep 30, 2025 | 139.69 Mn |
| Jun 30, 2025 | 139.86 Mn |
| Mar 31, 2025 | 123.05 Mn |
| Dec 31, 2024 | 106.42 Mn |
| Sep 30, 2024 | 109.48 Mn |
| Jun 30, 2024 | 111.39 Mn |
| Mar 31, 2024 | 112.73 Mn |
| Dec 31, 2023 | 113.57 Mn |
| Sep 30, 2023 | 116.01 Mn |
| Jun 30, 2023 | 118.40 Mn |
| Mar 31, 2023 | 120.87 Mn |
| Dec 31, 2022 | 123.52 Mn |
| Sep 30, 2022 | 139.23 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 107.50 Mn |
| Dec 31, 2021 | 23.92 Mn |
| Sep 30, 2021 | 25.68 Mn |